MSX MIRO SCIENCES LTD

—Mkt Cap: —P/E: —3d ago

Miro Sciences Ltd engages in the research and development of biomedical products targeting neurodegenerative conditions and immune-mediated inflammatory diseases. Its lead product is the EmtinB drug for the treatment of …

Key Statistics

Company

Market Cap—

Enterprise Value10.50M USD

Revenue (TTM)282.85K USD

Gross Profit181.43K USD

Net Income (TTM)-3.30M USD

Revenue/Share0.0010 AUD

Last Price—

Fiscal Year EndJun 2026

MR QuarterJun 2026

Employees—

CountryAU

Sector—

Industry—

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-4.50

EV/Revenue37.11

P/S48.39

P/B1.32

EPS (TTM)-0.01

EPS (Forward)—

52W Range

—

52W High—

52W Low—

Profitability

Gross Margin64.14%

Oper. Margin-3407.53%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-31.69%

ROA-30.91%

ROIC-49.76%

ROCE-34.40%

Growth

Revenue Growth87.60%

Earnings Growth—

Cash Flow & Leverage

Operating CF-1.95M USD

CapEx (TTM)—

FCF Margin-257.75%

FCF Yield—

Net Debt-3.19M USD

Net Debt/EBITDA1.37

Net Debt/FCF—

Balance Sheet

Debt/Equity0.01

Current Ratio14.27

Quick Ratio14.15

Book Value/Sh0.04 AUD

Cash/Share0.01 AUD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 AUD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)0.4300 AUD

Target Range0.4300 AUD – 0.4300 AUD

# Analysts1

Ownership

Shares Out.389.72M

Float152.64M

Insiders45.21%

Institutions0.00%

Technical

SMA 500.0569 AUD

SMA 2000.0569 AUD

Beta1.23

S&P 52W Chg10.63%

Avg Vol (30d)—

Avg Vol (10d)194.69K

Technical Indicators

RSI (14)34.8

MACD-0.0023

MACD Signal-0.0015

MACD Hist.-0.0007

BB Upper0.0647 AUD

BB Middle0.0576 AUD

BB Lower0.0505 AUD

BB Width24.62%

ATR (14)0.0037 AUD

Vol Ratio (20d)0.48x